Manufacturer
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD
Contents
Cimetidine
Indication
Prophylaxis of gastrointestinal haemorrhage from stress ulceration, Benign gastric and duodenal ulceration, Pancreatic insufficiency, Non-ulcer dyspepsia, Zollinger-Ellison syndrome, Gastro-oesophageal reflux disease, Prophylaxis of acid aspiration during general anaesthesia, Short bowel syndrome.
Instruction
Should be taken with food.
Drug interaction
Reduces absorption of dasatinib, ketoconazole, itraconazole and posaconazole. May increase serum levels of phenytoin, theophylline, lidocaine, hydroxyzine and oral anticoagulants. Absorption may be reduced by antacids. Decreased bioavailability w/ metoclopramide, sucralfate or propantheline. May potentiate the myelosuppressive effects (e.g. agranulocytosis, neutropenia) of myelosuppressive drugs (e.g. antimetabolites, alkylating agents) or therapies (e.g. radiation).
Malaysia
